TNFRSF4 and systemic lupus erythematosus: There was no significant difference comparing the percentages of IL-22-producing CD134+CD4+ T-cells in SLE patients with lupus nephritis versus patients without lupus nephritis (13.5 ± 9.7% vs. 9.0 ± 8.4%; p = 0.19) and HC, respectively.